Yatein from Chamaecyparis obtusa suppresses herpes simplex virus type 1 replication in HeLa cells by interruption the immediate-early gene expression

Antiviral Research

Volumn 70, Issue 3, 2006, Pages 112-120

  Kuo, Yuh Chi ^a   Kuo, Yueh Hsiung ^b   Lin, Yuang Lian ^c   Tsai, Wei Jern ^c  

^a FU JEN CATHOLIC UNIVERSITY   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^c NATIONAL RESEARCH INSTITUTE OF CHINESE MEDICINE   (Taiwan)

Author keywords

Trans induction factor; gB; HSV 1; ICP4; Yatein

Indexed keywords

ACICLOVIR; BRYOPHULLUM PINNATUM; CHAMAECYPARIS OBTUSA EXTRACT; DUCHESNEA INDICA EXTRACT; FICUS PUMILA EXTRACT; GLYCOPROTEIN B; HIBISCUS TAIWANENSIS EXTRACT; ILEX ASPRELLA EXTRACT; MESSENGER RNA; MULTIPROTEIN COMPLEX; PLANT EXTRACT; PROTEIN C; PROTEIN ICP0; PROTEIN ICP4; PROTEIN INDUCTION FACTOR; RADIX CLERODENDRI EXTRACT; SELAGINELLA LEPTOPHYLLA EXTRACT; STRUCTURAL PROTEIN; UNCLASSIFIED DRUG; VIBURNUM LUZUNICOM EXTRACT; VIRUS PROTEIN; YATEIN;

ANTIVIRAL ACTIVITY; ARTICLE; BIOASSAY; CELL CYCLE ARREST; CELL VIABILITY; CHAMAECYPARIS; CHINESE HERB; CONTROLLED STUDY; CYTOTOXICITY; DNA REPLICATION; DNA SYNTHESIS; DRUG EFFECT; DRUG IDENTIFICATION; DRUG INHIBITION; DRUG ISOLATION; DRUG MECHANISM; DRUG STRUCTURE; FRACTIONATION; GEL MOBILITY SHIFT ASSAY; GENE EXPRESSION; HELA CELL; HERPES SIMPLEX VIRUS 1; HUMAN; HUMAN CELL; IMMEDIATE EARLY GENE; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; VIROGENESIS; VIRUS ADSORPTION; VIRUS GENE; VIRUS REPLICATION;

4-BUTYROLACTONE; ANTIVIRAL AGENTS; CHAMAECYPARIS; DIOXOLES; DRUGS, CHINESE HERBAL; GENES, IMMEDIATE-EARLY; HELA CELLS; HERPESVIRUS 1, HUMAN; HUMANS; IMMEDIATE-EARLY PROTEINS; VIRUS REPLICATION;

CHAMAECYPARIS OBTUSA; HUMAN HERPESVIRUS 1;

EID: 33646769967     PISSN: 01663542     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.antiviral.2006.01.011     Document Type: Article

References (45)

1. Adlercreutz H. Epidemiology of phytoestrogens. Bailliere Clin. Endocr. 12 (1998) 605-623
2. Alrabiah F.A., and Sacks S.L. New antiherpes virus agents: their targets and therapeutic potential. Drugs 52 (1996) 17-32
3. Arisawa M., Fujita A., Hayashi T., Hayashi K., Ochiai H., and Morita N. Cytotoxic and antiherpetic activity of phloroglucinol derivatives from Mallotus japonicus (Euphorbiaceae). Chem. Pharm. Bull. 38 (1990) 1624-1626
4. Bacon T.H., Howard B.A., Spender L.C., and Boyd M.R. Activity of penciclovir in antiviral assays against herpes simplex virus. J. Antimicrob. Chemother. 37 (1996) 303-313
5. Bastos J.K., Carvalho J.C., de Souza G.H., Pedrazzi A.H., and Sarti S.J. Anti-inflammatory activity of cubebin, a lignan from the leaves of Zanthoxyllum naranjillo Griseb. J. Ethnopharmacol. 75 (2001) 279-282
6. Betz U.A.K., Fischer R., Kleymann G., Hendrix M., and Rübsamen-Waigmann H. Potent in vivo antiviral activity of the herpes simplex virus primase-helicase inhibitor BAY 57-1293. Antimicrob. Agents Chemother. 46 (2002) 1766-1772
7. Boulware S.L., Bronstein J.C., Nordby E.C., and Weber P.C. Identification and characterization of a benzothiophene inhibitor of herpes simplex virus type 1 replication which acts at the immediate early stage of infection. Antivir. Res. 51 (2001) 111-125
8. Chibo D., Druce J., Sasadeusz J., and Birch C. Molecular analysis of clinical isolates of acyclovir resistant herpes simplex virus. Antivir. Res. 61 (2004) 83-91
9. Coen D.M. Antiviral drug resistance in herpes simplex virus. Adv. Exp. Med. Biol. 394 (1996) 49-57
10. Cone R.W., Hobson A.C., Palmer J., Remington M., and Corey L. Extended duration of herpes simplex virus DNA in genital lesions detected by the polymerase chain reaction. J. Infect. Dis. 164 (1991) 757-760
11. Corey L., and Spear P.G. Infections with herpes simplex viruses (1). N. Engl. J. Med. 314 (1986) 686-691
12. Corey L., Wald A., Celum C.L., and Quinn T.C. The effects of herpes simplex virus-2 on HIV-1 acquisition and transmission: a review of two overlapping epidemics. J. Acquir. Immune Defic. Syndr. 35 (2004) 435-445
13. Craigo J., Callahan M., Huang R.C., and De Lucia A.L. Inhibition of human papillomavirus type 16 gene expression by nordihydroguaiaretic acid plant lignan derivatives. Antivir. Res. 47 (2000) 19-28
14. Darby G. A history of antiherpes research. Antivir. Chem. Chemother. 5 Suppl. 1 (1994) 3-9
15. Elion G.B., Furman P.A., Fyfe J.A., de Miranda P., Beauchamp L., and Schaeffer H.J. Selectivity of action of an antiherpetic agent, 9-(2-hydroxyethoxymethyl) guanine. Proc. Natl. Acad. Sci. U.S.A. 74 (1977) 5716-5720
16. Farnsworth N.R. Ethnopharmacology and future drug development: the North American experience. J. Ethnopharmacol. 38 (1993) 145-152
17. Ferrea G., Canessa A., Sampietro F., Cruciani M., Romussi G., and Bassetti D. In vitro activity of a Combretum micranthum extract against herpes simplex virus types 1 and 2. Antivir. Res. 21 (1993) 317-325
18. Furman P.A., Clair M.H., St. Fyfe J.A., Rideout J.L., Keller P.M., and Elion G.B. Inhibition of herpes simplex virus-induced DNA polymerase activity and viral DNA replication by 9-(2-hydroxyethoxymethyl) guanine and its triphosphate. J. Virol. 32 (1979) 72-77
19. Honess R.W., and Roizman B. Regulation of herpesvirus macromolecular synthesis: sequential transition of polypeptide synthesis required functional viral polypeptides. Proc. Natl. Acad. Sci. U.S.A. 72 (1975) 1276-1280
20. Honess R.W., and Roizman B. Regulation of herpesvirus macromolecular synthesis. I. Cascade regulation of the synthesis of three groups of viral proteins. J. Virol. 14 (1974) 8-19
21. Houghton P.J. The role of plants in traditional medicine and current therapy. J. Altern. Complem. Med. 1 (1995) 131-143
22. Hwang G.S., Phuong N.T., Park K.R., Kim Y.H., Kim K.H., and Kang J.S. Distribution of (-)-yatein in Cupressaceae family analysed by high performance liquid chromatography. Arch. Pharm. Res. 27 (2004) 35-39
23. Jones P.C., and Roizman B. Regulation of herpesvirus macromolecular synthesis. VIII. The transcription program consists of three phases during which both extent of transcription and accumulation of RNA in the cytoplasm are regulated. J. Virol. 31 (1979) 299-314
24. Kimberlin D.W., and Whitley R.J. Antiviral resistance: mechanisms, clinical significance, and future implications. J. Antimicrob. Chemother. 37 (1996) 403-421
25. Kleymann G., Fischer R., Betz U.A.K., Hendrix M., Bender W., Schneider U., Handke G., Eckenberg P., Hewlett G., Pevzner V., Baumeister J., Weber O., Henninger K., Keldenich J., Jensen A., Kolb J., Bach I., Popp A., Mäben J., Frappa I., Haebich D., Lockhoff O., and Rübsamen-Waigmann H. New helicase-primase inhibitors as drug candidates for the treatment of herpes simplex disease. Nat. Med. 8 (2002) 392-398
26. Koulman A., Batterman S., van Putten F.M., Bos R., and Quax W.J. Lignan profiles of indoor-cultivated Antheriscus sylvestris. Planta Med. 69 (2003) 959-961
27. Kuo Y.C., and Lin C.Y. Recurrent herpes simplex virus type 1 infection precipitated by the impaired production of interleukin-2, alpha-interferon, and cell-mediated cytotoxicity. J. Med. Virol. 31 (1990) 183-189
28. Kuo Y.C., Yang N.S., Chou C.J., Lin L.C., and Tsai W.J. Regulation of cell proliferation, gene expression, production of cytokines, and cell cycle progression in primary human T lymphocytes by piperlactam S isolated from Piper kadsura. Mol. Pharmacol. 58 (2000) 1057-1066
29. Kuo Y.C., Sun C.M., Ou J.C., and Tsai W.J. A tumor cell growth inhibitor from Polygonum hypoleucum Ohwi. Life Sci. 61 (1997) 2335-2344
30. Kuo Y.C., Chen C.C., Tsai W.J., and Ho Y.H. Regulation of herpes simplex virus type 1 replication in Vero cells by Psychotria serpens: relationship to gene expression, DNA replication, and protein synthesis. Antivir. Res. 51 (2001) 95-109
31. Kuo Y.C., Liu W.T., and Lin C.Y. Herpes simplex virus type 1 genes in human mononuclear cells and affecting cell-mediated immunity. J. Med. Virol. 41 (1993) 138-145
32. Kuo Y.C., Lin L.C., Tsai W.J., Chou C.J., Kung S.H., and Ho Y.H. Samaragenin B identified from Limonium sinense suppressed herpes simplex virus type 1 replication in Vero cells by regulation of viral macromolecular synthesis. Antimicrob. Agents Chemother. 46 (2002) 2854-2864
33. Mackem S., and Roizman B. Structural features of the herpes simplex alpha gene 4, 0, 27 promoter-regulatory sequences which confer a regulation on chimeric thymidine kinase genes. J. Virol. 44 (1982) 939-949
34. Mann S.L., Meyers J.D., Holmes K.L., and Corey L. Prevalence and incidence of herpesvirus infections among homosexually active men. J. Infect. Dis. 149 (1984) 1026-1027
35. Marchetti M., Pisani S., Pietropaola V., Seganti L., Nicoletti R., Degener A., and Orsi N. Antiviral effect of a polysaccharide from Sclerotium glucanicum towards herpes simplex virus type 1 infection. Planta Med. 62 (1996) 303-307
36. McKnight J.L.C., Kristie T.M., and Roizman B. Binding of the virion protein mediating α gene induction in herpes simplex virus 1-infected cells to its cis site required cellular proteins. Proc. Natl. Acad. Sci. U.S.A. 84 (1987) 7061-7065
37. Medarde M., Pelaez-Lamamie de Clariac R., Lopez J.L., Gravalos D.G., and San Feliciano S. Synthesis, antitumoral and antiviral evaluation of halo- and demethyl-yatein derivatives. Arch. Pharm. 328 (1995) 640-644
38. Pope L.E., Marceletti J.F., Katz L.R., and Katz D.H. Anti-herpes simplex virus activity of n-docosanol correlates with intracellular metabolic conversion of the drug. J. Lipid Res. 37 (1996) 2167-2178
39. Roizman B., and Sears A.E. Herpes simplex virus and their replication. In: Fields B.N., Knipe D.M., and Howley P.M. (Eds). Fundamental Virology. 3rd ed. (1996), Lippincott-Raven Publishers, Philadelphia 2231-2295
40. Sacks S.L., Thisted R.A., Jones T.M., Barbarash R.A., Mikolich D.J., Ruoff G.E., Jorizzo J.L., Gunnill L.B., Katz D.H., Khalil M.H., Morrow P.R., Yakatan G.J., Pope L.E., Berge J.E., and The Docosanol 10% Cream Study Group. Clinical efficacy of topical docosanol 10% cream for herpes simplex labialis: a multicenter, randomized, placebo-controlled trial. J. Am. Acad. Dermatol. 45 (2001) 222-230
41. Saiki P.K., Scharf S., Faloona F., Mullis K.B., Horn G., Erlich H.A., and Arnheim N. Enzymatic amplification of globin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia. Science 230 (1985) 1350-1354
42. Simõnes C.M.O., Amoros M., and Girre L. Mechanism of antiviral activity of triterpenoid saponins. Phytother. Res. 21 (1999) 317-325
43. Sydiskis R.J., Owen D.G., Lohr J.L., Rosler K.H., and Blomster R.N. Inactivation of enveloped viruses by anthraquinones extracted from plants. Antimicrob. Agents Chemother. 35 (1991) 2463-2466
44. Vanden Berghe D.A., Vlietinck A.J., and Van Hoof L. Plant products as potential antiviral agents. Bull. Inst. Pasteur 84 (1986) 101-147
45. Waggoner-Fountain L.A., and Grossman L.B. Herpes simplex virus. Pediatr. Rev. 25 (2004) 86-93